Androgens are well known to influence cell behaviour in prostate cancer, and a role for testosterone in β-catenin signalling in prostate cancer is suggested by data showing that androgen receptor activation potentiates Wnt signalling (Schweizer et al, 2008). This evidence concerns the gene AR and prostate carcinoma.